Neuphoria Therapeutics (NEUP) Intangibles (2020 - 2026)
Neuphoria Therapeutics (NEUP) recorded Intangibles of $4.14 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 13.8% from $4.8 million a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Intangibles (2020 - 2026) Analysis & Trends
Starting with fiscal Q4 2020, Neuphoria Therapeutics' Intangibles history includes 16 quarters.
- Annual Intangibles has declined for six straight fiscal years, with a five-year compound annual growth rate of -11.6% (FY2021 to FY2026).
- Across earlier fiscal years, Intangibles came in at $4.8 million in FY2025 (-12.1%), $5.47 million in FY2024 (-10.8%), $6.13 million in FY2023 (-13.0%) and $7.05 million in FY2022 (-8.0%).
- The fiscal Q4 2026 figure is the lowest quarterly Intangibles in data going back to fiscal Q4 2020.
- On a year-over-year basis, Intangibles has declined for nine consecutive quarters, with an average decline of 12.4% over the last eight quarters.
- Over the past five years, the year-over-year decline in Intangibles ranged from 8.0% (fiscal Q4 2022) to 13.8% (fiscal Q4 2026).
- Per Business Quant, the preceding three fiscal quarters came in at $4.31 million (Q3 2026), $4.47 million (Q2 2026) and $4.64 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 4.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.14 Mn |
| Mar 31, 2026 | 4.31 Mn |
| Dec 31, 2025 | 4.47 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.97 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.47 Mn |
| Mar 31, 2024 | 5.63 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 6.15 Mn |
| Jun 30, 2022 | 7.05 Mn |
| Jun 30, 2021 | 7.66 Mn |
| Jun 30, 2020 | 15.93 Mn |
API Access
Neuphoria Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();